These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Letter: Levamisole and the immune response. N Engl J Med; 1973 Nov; 289(21):1148-9. PubMed ID: 4585358 [No Abstract] [Full Text] [Related]
6. [Clinical use of levamisole - perspectives and warnings]. Farber NA Ter Arkh; 1980; 52(1):95-100. PubMed ID: 7368132 [No Abstract] [Full Text] [Related]
7. [Levamisole - a new immunostimulant]. Rachkov SM Ter Arkh; 1976; 48(11):133-8. PubMed ID: 1088219 [No Abstract] [Full Text] [Related]
8. Levamisole induced granulocytopenia and thrombocytopenia in a case of Crohn's colitis. Sategna-Guidetti C; Peyre S Gastroenterol Clin Biol; 1979 Jan; 3(1):104. PubMed ID: 437394 [No Abstract] [Full Text] [Related]
10. [Use of levamisole in nephrological practice (a review of the literature)]. Drannik GN; Kolesnik NA Vrach Delo; 1982 May; (5):12-6. PubMed ID: 7051554 [No Abstract] [Full Text] [Related]
12. [Effect of levamisole on the immunological indicators in chronic glomerulonephritis]. Gordovskaia NB; Shilov EM; Savitskiĭ SN; Miroshnichenko NG; Mukhin NA Ter Arkh; 1980; 52(4):28-31. PubMed ID: 7404334 [No Abstract] [Full Text] [Related]
13. Effectiveness of levamisole on stromal herpetic keratitis. Sakata H; Yoshida H; Hiyama N; Kondo H; Hirakawa Y Hiroshima J Med Sci; 1983 Dec; 32(4):555-9. PubMed ID: 6678909 [No Abstract] [Full Text] [Related]
14. Possible toxicity of levamisole in children with rheumatoid arthritis. Prieur AM; Buriot D; Lefur JM; Griscelli C J Pediatr; 1978 Aug; 93(2):304-5. PubMed ID: 671173 [No Abstract] [Full Text] [Related]
15. [Levamisole-induced changes of cellular immunity in patients with staphyloderma and indications for levamisole administration]. Lesnitskiĭ AI Vestn Dermatol Venerol; 1982; (1):14-9. PubMed ID: 6978577 [No Abstract] [Full Text] [Related]
16. Levamisole: a synthetic immunopotentiator under evaluation. Hadden JW Clin Bull; 1975; 5(1):32-3. PubMed ID: 819182 [No Abstract] [Full Text] [Related]
17. Levamisole in cancer treatment: modifications in time of cellular immunity. (Preliminary report). Luporini G; Fraschini P; Labianca R; Negri R Boll Ist Sieroter Milan; 1979 Nov; 58(5):435-9. PubMed ID: 576007 [TBL] [Abstract][Full Text] [Related]
18. [Use of clinico-immunological indices for the evaluation of the efficacy of the basic therapy of rheumatoid arthritis]. Tsitlanadze VG; Dzidziguri LM; Tkemaladze LM; Kartvelishvili EIu; Shakulashvili NA Ter Arkh; 1981; 53(7):72-4. PubMed ID: 6974910 [No Abstract] [Full Text] [Related]
19. Levamisole and cell-mediated immunity and serum-immunoglobulins in rheumatoid arthritis. Szpilman H; Luft S; Glińska-Urban D; Fischer W; Plachecka M Lancet; 1976 Jul; 2(7978):208-9. PubMed ID: 73839 [No Abstract] [Full Text] [Related]